Bibliography
- Nissinen MJ, Karlstedt K, Castren E, Panula P. Expression of histidine decarboxylase and cellular histamine-like immunoreactivity in rat embryogenesis. J Histochem Cytochem 1995;43:1241-52
- Hill SJ. Distribution, properties and functional characteristics of three classes of histamine receptors. Pharmacol Rev 1990;42:45-83
- Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol 2006;147:S127-35
- Zhang M, Thurmond RL, Dunford PJ. The histamine H4 receptor: A novel modulator of inflammatory and immune disorders. Pharmacol Ther 2007;113:594-606
- Black JW, Duncan WAM, Durant CJ, et al. Definition and antagonism of histamine H2-receptors. Nature 1972;236:385-90
- Black JW, Shankley NP. How does gastrin act to stimulate oxyntic cell secretion? Trends Pharmacol Sci 1987;8:486-90
- Soll AH, Berglindh T. Physiology of isolated gastric glands and parietal cells: Receptors and effectors regulating function. Physiology of the Gastrointestinal Tract. New York, Raven Press, 1987;883-909
- Lovenberg TW, Roland BL, Wilson SJ, et al. Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 1999;55:1101-7
- Masaki T, Yoshimatsu H. Therapeutic approach of histamine H3 receptors in obesity. Recent Patents CNS Drug Discov 2007;2:238-40
- Stocking EM, Letavic MA. Histamine H3 antagonists as wake-promoting and pro-cognitive agents. Curr Top Med Chem 2008;8:988-1002
- Masaki T, Yoshimatsu H. Neuronal histamine and its receptors in obesity and diabetes. Curr Diabetes Rev 2007;3:212-6
- Masaki T, Yoshimatsu H. Neuronal histamine and histamine receptors in food intake and obesity. Mini Rev Med Chem 2007;7:821-5
- Jörgensen EA, Knigge U, Warberg J, Kjaer A. Histamine and the regulation of body weight. Neuroendocrinology 2007;86:210-4
- Wijtmans M, Leurs R, de Esch I. Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas. Expert Opin Investig Drugs 2007;16:967-85
- Letavic MA, Barbier AJ, Dvorak CA, Carruthers NI. Recent medicinal chemistry of the histamine H3 receptor. Prog Med Chem 2006;44:181-206
- Tokita S, Takahashi K, Kotani H. Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. J Pharmacol Sci 2006;101:12-8
- Esbenshade TA, Fox GB, Cowart MD. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv 2006;6:77-88
- Nguyen T, Shapiro DA, George SR, et al. Discovery of a novel member of the histamine receptor family. Mol Pharmacol 2001;59:427-33
- Oda T, Morikawa N, Saito Y, et al. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;275:36781-6
- Liu C, Ma X, Jiang X, et al. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol 2001;59:420-6
- Morse KL, Behan J, Laz TM, et al. Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001;296:1058-66
- Zhu Y, Michalovich D, Wu H, et al. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 2001;59:434-41
- Damaj BB, Becerra CB, Esber HJ, et al. Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J Immunol 2007;179:7907-15
- Sander LE, Lorentz A, Sellge G, et al. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut 2006;55:498-504
- Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol 2004;113:552-7
- Coge F, Guénin SP, Rique H, et al. Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun 2001;284:301-9
- Strakhova MI, Nikkel AL, Manelli AM, et al. Localization of histamine H(4) receptors in the central nervous system of human and rat. Brain Res 2008. Published online 19 November 2008, doi:10.1016/j.brainres.2008.11.018
- Fokkens WJ, Godthelp T, Holm AF, et al. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study. Clin Exp Allergy 1992;22:701-10
- Slater A, Smallman LA, Drake-Lee AB. Increase in epithelial mast cell numbers in the nasal mucosa of patients with perennial allergic rhinitis. J Laryngol Otol 1996;110:929-33
- Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003;305:1212-21
- Buckland KF, Williams TJ, Conroy DM. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol 2003;140:1117-27
- Ling P, Ngo K, Nguyen S, et al. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004;142:161-71
- Huang JF, Thurmond RL. The new biology of histamine receptors. Curr Allergy Asthma Rep 2008;8:21-7
- Gantner F, Sakai K, Tusche MW, et al. Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J Pharmacol Exp Ther 2002;303:300-7
- Takeshita K, Sakai K, Bacon KB, Gantner F. Critical role of histamine H4 receptor in leukotriene B4 production and mast cell dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 2003;307:1072-8
- Thurmond RL, Desai PJ, Dunford PJ, et al. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004;309:404-13
- Coruzzi G, Adami M, Guaita E, et al. Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 2007;563:240-4
- Dunford PJ, O'Donnell N, Riley JP, et al. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 2006;176:7062-70
- Breunig E, Michel K, Zeller F, et al. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol 2007;583:731-42
- Dunford PJ, Williams KN, Desai PJ, et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007;119:176-83
- Smith FM, Haskelberg H, Tracey DJ, Moalem-Taylor G. Role of histamine H3 and H4 Receptors in mechanical hyperalgesia following peripheral nerve injury. Neuroimmunomodulation 2007;14:317-25
- Altenbach RJ, Adair RM, Bettencourt BM, et al. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem 2008;51:6571-80
- Cowart MD, Altenbach RJ, Liu H, et al. Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 2008;51:6547-57
- Altenbach RJ, Liu H, Drizin I, et al. A method for pain treatment. WO2008060766; 2008
- Liu H, Altenbach RJ, Carr TL, et al. cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem 2008;51:7094-8
- O'Reilly M, Alpert R, Jenkinson S, et al. Identification of a histamine H4 receptor on human eosinophils–role in eosinophil chemotaxis. J Recept Signal Transduct Res 2002;22:431-48
- Bakker RA, Schoonus SB, Smit MJ, et al. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 2001;60:1133-42
- Leurs R, Smit MJ, Menge WM, Timmerman H. Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol 1994;112:847-54
- Lim HD, van Rijn RM, Ling P, et al. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 2005;314:1310-21
- Bell JK, McQueen DS, Lima JJ. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br J Pharmacol 2004;142:374-80
- Burns S, Hamley P. Imidazol derivatives of piperdine as histamine antagonists. WO2005014579; 2005
- Girard P, Pansart Y, Coppè MC, et al. Role of the histamine system in nefopam-induced antinociception in mice. Eur J Pharmacol 2004;503:63-9
- Cannon KE, Hough LB. Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors. J Pain 2005;6:193-200
- Farzin D, Norsati F. Modification of formalin-induced nociception by different histamine receptor agonists and antagonists. Eur Neuropsychoparmacol 2007;17:122-8
- Kohno S, Nakao S, Ogawa K, et al. Possible participation of histamine H3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn J Pharmacol 1994;66:173-80
- Bissonnette EY. Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors. Am J Respir Cell Mol Biol 1996;14:620-6
- Hashimoto T, Harusawa S, Araki L, et al. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5-[1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine. J Med Chem 2003;46:3162-5
- Durant GJ, Ganellin CR, Parsons ME. Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem 1975;18(9):905-9
- Smits RA, Lim HD, Stegink B, et al. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives. J Med Chem 2006;49:4512-6
- Lim HD, Smits RA, Bakker RA, et al. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. J Med Chem 2006;49:6650-1
- Jablonowski JA, Grice CA, Chai W, et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 2003;46:3957-60
- Liu C, Wilson SJ, Kuei C, Lovenberg TW. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 2001;299:121-30
- Venable JD, Thurmond RL. Development and chemistry of histamine H4 receptor ligands as potential modulators of inflammatory and allergic responses. Anti-Inflamm Anti-Allergy Agents Med Chem 2006;5:307-22
- Venable JD, Cai H, Chai W, et al. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists. J Med Chem 2005;48:8289-98
- Cowden J. ‘Targets and Therapeutics in Allergic Disease’ block symposium, San Diego: Experimental Biology meeting; 2008
- Carruthers NI, Dvorak CA, Edwards JP, et al. Heterocyclic compounds. WO2004022060; 2004
- Dunford PJ, Edwards JP, Karlsson L, et al. Use of indolyl derivatives for the manufacture of a medicament for the treatment of allergic rhinitis. WO2004022061; 2004
- Carruthers NI, Chai W, Dvorak CA, et al. Heterocyclic compounds. WO2002072548; 2002
- Edwards JP, Savall BM, Shah CR. Indoles and benzoimidazoles as modulators of the histamine h4 receptor. WO2007117401; 2007
- Cai H, Carruthers NI, Dvorak CA, et al. Thieno- and furano-pyrroles and their use as histamine H4 receptor antagonists. WO2004022537; 2004
- Terzioglu N, van Rijn RM, Bakker RA, et al. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. Bioorg Med Chem Lett 2004;14:5251-6
- Varga C, Horvath K, Berko A, et al. Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur J Pharmacol 2005;522:130-8
- Lane CAL, Price DA. Octahydropyrrolo[3,4-c]pyrrole derivatives. WO2006056848; 2006
- Lee-Dutra A, Arienti KL, Buzard DJ, et al. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands. Bioorg Med Chem Lett 2006;16:6043-8
- Arienti KL, Breitenbucher JG, Buzard DJ, et al. Benzoimidazole compounds. WO2005044807; 2005
- Edwards JP, Kindrachuk DE, Venable JD. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor. WO2007117399; 2007
- Edwards JP, Kindrachuk DE, Venable JD. Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor. WO2007117400; 2007
- Buzard DJ, Edwards JP, Kindrachuk DE, Venable JD. Imidazole compounds. WO2005092066; 2005
- Watanabe M, Kazuta Y, Hayashi H, et al. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure. J Med Chem 2006;49:5587-96
- Edwards JP, Venable JD. Quinoxaline compounds. WO2005033088; 2005
- Smits RA, Lim HD, Hanzer A, et al. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo. J Med Chem 2008;51:2457-67
- Smits RA, Van Lim HD, Leurs R, et al. Quinazolines and related heterocyclic compounds, and their therapeutic use. WO2008003702; 2008
- Sato H, Tanaka K, Shimazaki M, et al. 2-Aminopyrimidine derivatives. WO2005054239; 2005
- Sato H, Fukushima K, Shimazaki M, et al. 2-aminopyrimidine derivatives. WO2005014556; 2005
- Cai H, Chavez F, Edwards JP, et al. 2-aminopyrimidine modulators of the histamine h4 receptor. WO2008100565; 2008
- Bell AS, Lane CAL, Mowbray CE, et al. Pyrimidine derivatives. WO2007072163; 2007
- Carceller GE, Salas Solana J, Soliva Soliva R, et al. 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity. WO2007031529; 2007
- Raphy G, Watson RJ, Hannah D, et al. Novel 2 amino-pyrimidine derivatives, processes for preparing them, pharmaceutical compositions thereof. WO2008031556; 2008
- Harris N, Higgs C, Wren S, et al. Pyrimidine compounds as histamine modulators. WO2006050965; 2006
- Reid A, Wilson F, Dyke H, et al. Amino pyrimidine compounds for the treatment of inflammatory disorders. WO2007090852; 2007
- Dyke H, Price S, Cramp S. Pyrimidine compounds for the treatment of inflammatory disorders. WO2007039467; 2007
- Reid A, Wilson F, Dyke H, et al. Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders. WO2007090853; 2007
- Reid A, Wilson F, Dyke H, et al. Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders. WO2007090854; 2007
- Chavez F, Curtis MP, Edwards JP, et al. Benzofuro-and benzothienopyryimidine modulators of the histamine H4 receptor. WO2008008359; 2008
- Watson RJ, Hannah D, Pegurier C, et al. Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof. WO2008074445; 2008
- Altenbach RJ, Liu H, Drizin I, et al. Macrocyclic benzofused pyrimidine derivatives. WO2008060767; 2008
- Kiss R, Kiss B, Könczöl A, et al. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. J Med Chem 2008;51:3145-53
- Parasrampuria J, Ingerman A, Janssens F, Megens A. Ocular allergy treatments. WO2007117971; 2007
- Richard Hale SMR's Emerging Therapies in Respiratory Disease Meeting, Wellcome Trust Conference Centre, Hinxton, Cambridge, United Kingdom; 2007
- Fung-Leung WP, Thurmond RL, Ling P, Karlsson L. Histamine H4 receptor antagonists: The new antihistamines. Curr Opin Invest Drugs 2004;5:1174-83
- Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 2008;7:41-53
- Dunford PJ, Karlsson L, Thurmond RL. Combination histamine H1R and H4R antagonist therapy for treating pruritus. WO2007120690; 2007
- Yeadon M. Combination for treating inflammatory diseases. WO2005089748; 2005
- Van Hoecke H, Vandenbulcke L, Van Cauwenberge P. Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update. Drugs 2007;67:2717-26
- Anthes JC, West RE, Hey JA, Aslanian RG. Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis. WO2004066960; 2004